223 related articles for article (PubMed ID: 16131979)
1. Gastrointestinal outcomes and confounders in cystic fibrosis.
Borowitz D; Durie PR; Clarke LL; Werlin SL; Taylor CJ; Semler J; De Lisle RC; Lewindon P; Lichtman SM; Sinaasappel M; Baker RD; Baker SS; Verkade HJ; Lowe ME; Stallings VA; Janghorbani M; Butler R; Heubi J
J Pediatr Gastroenterol Nutr; 2005 Sep; 41(3):273-85. PubMed ID: 16131979
[No Abstract] [Full Text] [Related]
2. Pancreatic enzyme therapy and gastrointestinal symptoms in patients with cystic fibrosis.
Walkowiak J; Lisowska A
J Pediatr; 2005 Dec; 147(6):870-1. PubMed ID: 16356455
[No Abstract] [Full Text] [Related]
3. [Comparison of 2 pancreatic enzyme preparations in the treatment of digestive insufficiency in mucoviscidosis (cystic fibrosis)].
Gottschalk B; Wiesemann HG; Stephan U
Monatsschr Kinderheilkd; 1988 Sep; 136(9):626-9. PubMed ID: 3237230
[TBL] [Abstract][Full Text] [Related]
4. Treatment of infants and toddlers with cystic fibrosis-related pancreatic insufficiency and fat malabsorption with pancrelipase MT.
Van de Vijver E; Desager K; Mulberg AE; Staelens S; Verkade HJ; Bodewes FA; Malfroot A; Hauser B; Sinaasappel M; Van Biervliet S; Behm M; Pelckmans P; Callens D; Veereman-Wauters G
J Pediatr Gastroenterol Nutr; 2011 Jul; 53(1):61-4. PubMed ID: 21694537
[TBL] [Abstract][Full Text] [Related]
5. Re: fecal elastase: pancreatic status verification and influence on nutritional status in children with cystic fibrosis.
Walkowiak J; Lisowska A
J Pediatr Gastroenterol Nutr; 2006 Jan; 42(1):117; author reply 118. PubMed ID: 16385266
[No Abstract] [Full Text] [Related]
6. Detection and follow up of exocrine pancreatic insufficiency in cystic fibrosis: a review.
Leus J; Van Biervliet S; Robberecht E
Eur J Pediatr; 2000 Aug; 159(8):563-8. PubMed ID: 10968231
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic insufficiency in Cystic Fibrosis.
Singh VK; Schwarzenberg SJ
J Cyst Fibros; 2017 Nov; 16 Suppl 2():S70-S78. PubMed ID: 28986019
[TBL] [Abstract][Full Text] [Related]
8. Comparison of monoclonal and polyclonal ELISAs for fecal elastase in patients with cystic fibrosis and pancreatic insufficiency.
Borowitz D; Lin R; Baker SS
J Pediatr Gastroenterol Nutr; 2007 Feb; 44(2):219-23. PubMed ID: 17255835
[TBL] [Abstract][Full Text] [Related]
9. Comparison of two pancreatic enzyme products for exocrine insufficiency in patients with cystic fibrosis.
Taylor CJ; Thieroff-Ekerdt R; Shiff S; Magnus L; Fleming R; Gommoll C
J Cyst Fibros; 2016 Sep; 15(5):675-80. PubMed ID: 27013382
[TBL] [Abstract][Full Text] [Related]
10. [Not Available].
Lenglinger J; Hädrich M
Ther Umsch; 2016 Nov; 73(9):500-504. PubMed ID: 27805488
[No Abstract] [Full Text] [Related]
11. Safety and efficacy of Creon® micro in children with exocrine pancreatic insufficiency due to cystic fibrosis.
Kashirskaya NY; Kapranov NI; Sander-Struckmeier S; Kovalev V
J Cyst Fibros; 2015 Mar; 14(2):275-81. PubMed ID: 25066363
[TBL] [Abstract][Full Text] [Related]
12. [Physiopathology, diagnosis, and treatment of exocrine pancreatic insufficiency in patients with cystic fibrosis].
Guarner L
Gastroenterol Hepatol; 2005 Feb; 28 Suppl 1():29-32. PubMed ID: 15899235
[No Abstract] [Full Text] [Related]
13. Fecal elastase: pancreatic status verification and influence on nutritional status in children with cystic fibrosis.
Cohen JR; Schall JI; Ittenbach RF; Zemel BS; Stallings VA
J Pediatr Gastroenterol Nutr; 2005 Apr; 40(4):438-44. PubMed ID: 15795591
[TBL] [Abstract][Full Text] [Related]
14. Gastrointestinal, Pancreatic, and Hepatic Manifestations of Cystic Fibrosis in the Newborn.
Galante G; Freeman AJ
Neoreviews; 2019 Jan; 20(1):e12-e24. PubMed ID: 31261070
[TBL] [Abstract][Full Text] [Related]
15. Nutrition management in adults with cystic fibrosis.
Shape JM; Sala MA
Nutr Clin Pract; 2022 Apr; 37(2):256-264. PubMed ID: 35118712
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic Malnutrition in Children.
Normatov I; Sentongo T
Pediatr Ann; 2019 Nov; 48(11):e441-e447. PubMed ID: 31710363
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerability of Creon for Children in infants and toddlers with pancreatic exocrine insufficiency caused by cystic fibrosis: an open-label, single-arm, multicenter study.
Colombo C; Fredella C; Russo MC; Faelli N; Motta V; Valmarana L; Longo L; D'Orazio C
Pancreas; 2009 Aug; 38(6):693-9. PubMed ID: 19531972
[TBL] [Abstract][Full Text] [Related]
18. Animal models for pancreatic insufficiency in cystic fibrosis.
Lebenthal E; Lee PC
J Pediatr Gastroenterol Nutr; 1982; 1(1):9-11. PubMed ID: 7186029
[No Abstract] [Full Text] [Related]
19. Efficacy and tolerability of a new formulation of pancrelipase delayed-release capsules in children aged 7 to 11 years with exocrine pancreatic insufficiency and cystic fibrosis: a multicenter, randomized, double-blind, placebo-controlled, two-period crossover, superiority study.
Graff GR; Maguiness K; McNamara J; Morton R; Boyd D; Beckmann K; Bennett D
Clin Ther; 2010 Jan; 32(1):89-103. PubMed ID: 20171415
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of dietary fiber intake in Belgian children with cystic fibrosis: is there a link with gastrointestinal complaints?
Proesmans M; De Boeck K
J Pediatr Gastroenterol Nutr; 2002 Nov; 35(5):610-4. PubMed ID: 12454573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
